Home LiteratureArticle Details
PMID: 19158402 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

G(s)alpha deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency.

American journal of physiology. Cell physiology ·Vol. 296 ·No. 4 ·2009-04-00 ·Pages C930-40

Chen M, Feng HZ, Gupta D, Kelleher J, Dickerson KE, Wang J, Hunt D, Jou W, Gavrilova O, Jin JP, Weinstein LS

Abstract

The ubiquitously expressed G protein alpha-subunit G(s)alpha is required for receptor-stimulated intracellular cAMP responses and is an important regulator of energy and glucose metabolism. We have generated skeletal muscle-specific G(s)alpha-knockout (KO) mice (MGsKO) by mating G(s)alpha-floxed mice with muscle creatine kinase-cre transgenic mice. MGsKO mice had normal body weight and composition, and their serum glucose, insulin, free fatty acid, and triglyceride levels were similar to that of controls. However, MGsKO mice were glucose intolerant despite the fact that insulin sensitivity and glucose-stimulated insulin secretion were normal, suggesting an insulin-independent mechanism. Isolated muscles from MGsKO mice had increased basal glucose uptake and normal responses to a stimulator of AMP-activated protein kinase (AMPK), which indicates that AMPK and its downstream pathways are intact. Compared with control mice, MGsKO mice had reduced muscle mass with decreased cross-sectional area and force production. In addition, adult MGsKO mice showed an increased proportion of type I (slow-twitch, oxidative) fibers based on kinetic properties and myosin heavy chain isoforms, despite the fact that these muscles had reduced expression of peroxisome proliferator-activated receptor coactivator protein-1alpha (PGC-1alpha) and reduced mitochondrial content and oxidative capacity. Therefore G(s)alpha deficiency led to fast-to-slow fiber-type switching, which appeared to be dissociated from the expected change in oxidative capacity. MGsKO mice are a valuable model for future studies of the role of G(s)alpha signaling pathways in skeletal muscle adaptation and their effects on whole body metabolism.

MeSH Terms
AMP-Activated Protein Kinases/metabolism Animals Blood Glucose/metabolism Chromogranins Energy Metabolism Fatty Acids/metabolism Female GTP-Binding Protein alpha Subunits, Gs/deficiency,genetics Glucose Intolerance/genetics,metabolism,pathology,physiopathology Insulin/blood Insulin Resistance Male Mice Mice, Knockout Muscle Contraction Muscle Fibers, Fast-Twitch/metabolism,pathology Muscle Fibers, Slow-Twitch/metabolism,pathology Muscle Strength Muscle, Skeletal/metabolism,pathology,physiopathology Muscular Atrophy/genetics,metabolism,pathology,physiopathology Myosin Heavy Chains/metabolism Oxidation-Reduction Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha Signal Transduction Time Factors Trans-Activators/metabolism Transcription Factors
Chemicals
Blood Glucose Chromogranins Fatty Acids Insulin Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha Ppargc1a protein, mouse Trans-Activators Transcription Factors AMP-Activated Protein Kinases Gnas protein, mouse Myosin Heavy Chains GTP-Binding Protein alpha Subunits, Gs
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Chen Min
Metabolic Diseases Branch, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1752, USA. [email protected]
Feng Han-Zhong
Gupta Divakar
Kelleher James
Dickerson Kathryn E
Wang Jie
Hunt Desmond
Jou William
Gavrilova Oksana
Jin Jian-Ping
Weinstein Lee S
References (53)
53 references, click to expand
  1. Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency.
    J Clin Invest. 2005 Nov;115(11):3217-27 PMID: 16239968
  2. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk.
    J Clin Invest. 2007 Nov;117(11):3463-74 PMID: 17932564
  3. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.
    Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16260-5 PMID: 17053067
  4. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle.
    J Appl Physiol (1985). 2000 Jun;88(6):2219-26 PMID: 10846039
  5. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.
    J Biol Chem. 2004 Sep 24;279(39):41114-23 PMID: 15272020
  6. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans.
    Am J Physiol. 1995 Mar;268(3 Pt 1):E453-7 PMID: 7900793
  7. AMP-activated protein kinase and the regulation of glucose transport.
    Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E867-77 PMID: 16822958
  8. Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency.
    Cell Metab. 2006 Nov;4(5):363-75 PMID: 17084710
  9. Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.
    Endocrinology. 2004 Oct;145(10):4667-76 PMID: 15231693
  10. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.
    Endocr Rev. 2003 Feb;24(1):78-90 PMID: 12588810
  11. Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells.
    Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14379-84 PMID: 16980408
  12. The effect of a growth promoting drug, clenbuterol, on fibre frequency and area in hind limb muscles from young male rats.
    Biosci Rep. 1986 Mar;6(3):293-9 PMID: 2942194
  13. Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells.
    Br J Pharmacol. 2006 Feb;147(4):446-54 PMID: 16415914
  14. Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization.
    Diabetes. 2000 Oct;49(10):1635-42 PMID: 11016446
  15. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.
    Mol Cell. 1998 Nov;2(5):559-69 PMID: 9844629
  16. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.
    Diabetes. 1999 Sep;48(9):1706-12 PMID: 10480598
  17. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
    J Appl Physiol (1985). 1997 Jul;83(1):166-71 PMID: 9216960
  18. GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization.
    J Clin Invest. 2003 May;111(10):1555-62 PMID: 12750405
  19. Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.
    Diabetes. 2004 Nov;53(11):2901-9 PMID: 15504971
  20. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
    Endocrinology. 2007 Jul;148(7):3441-8 PMID: 17446185
  21. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport.
    Diabetes. 1998 Aug;47(8):1369-73 PMID: 9703344
  22. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.
    Nature. 2002 Aug 15;418(6899):797-801 PMID: 12181572
  23. Characterization of beta 1- and beta 2-adrenoceptors in rat skeletal muscles.
    Biochem Pharmacol. 1991 Oct 9;42(9):1783-9 PMID: 1681810
  24. Receptor and effector interactions of Gs. Functional studies with antibodies to the alpha s carboxyl-terminal decapeptide.
    FEBS Lett. 1989 Jun 5;249(2):189-94 PMID: 2500363
  25. Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.
    Pharmacol Ther. 2007 Aug;115(2):271-91 PMID: 17588669
  26. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony.
    J Clin Invest. 2006 Jul;116(7):1767-75 PMID: 16823474
  27. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist.
    Am J Physiol. 1988 Jun;254(6 Pt 1):E726-32 PMID: 3377073
  28. Sarcopenia and aging.
    Nutr Rev. 2003 May;61(5 Pt 1):157-67 PMID: 12822704
  29. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals.
    J Biol Chem. 2007 Oct 12;282(41):30014-21 PMID: 17702743
  30. Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance.
    Endocrinology. 2004 Sep;145(9):4094-102 PMID: 15166122
  31. Relationship between muscle fibre composition, glucose transporter protein 4 and exercise training: possible consequences in non-insulin-dependent diabetes mellitus.
    Acta Physiol Scand. 2001 Mar;171(3):267-76 PMID: 11412139
  32. Truncation by Glu180 nonsense mutation results in complete loss of slow skeletal muscle troponin T in a lethal nemaline myopathy.
    J Biol Chem. 2003 Jul 11;278(28):26159-65 PMID: 12732643
  33. Minireview: GNAS: normal and abnormal functions.
    Endocrinology. 2004 Dec;145(12):5459-64 PMID: 15331575
  34. Skeletal muscle beta-adrenergic receptors: variations due to fiber type and training.
    Am J Physiol. 1984 Feb;246(2 Pt 1):E160-7 PMID: 6320672
  35. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle.
    Am J Physiol. 1997 Dec;273(6):E1107-12 PMID: 9435525
  36. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.
    Nat Med. 2000 Aug;6(8):924-8 PMID: 10932232
  37. Regulatory mechanism of the ventromedial hypothalamus in enhancing glucose uptake in skeletal muscles.
    Brain Res. 1994 Jun 27;649(1-2):343-7 PMID: 7953650
  38. Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle.
    Ageing Res Rev. 2006 May;5(2):179-95 PMID: 16647308
  39. Differential regulation of myofilament protein isoforms underlying the contractility changes in skeletal muscle unloading.
    Am J Physiol Cell Physiol. 2007 Mar;292(3):C1192-203 PMID: 17108008
  40. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes.
    Cell Metab. 2006 Nov;4(5):407-14 PMID: 17084713
  41. Chronic effects of beta 2-adrenergic agonists on body composition and protein synthesis in the rat.
    Biosci Rep. 1984 Jan;4(1):83-91 PMID: 6141823
  42. Skeletal muscle adaptations during early phase of heavy-resistance training in men and women.
    J Appl Physiol (1985). 1994 Mar;76(3):1247-55 PMID: 8005869
  43. Molecular determinants of skeletal muscle mass: getting the "AKT" together.
    Int J Biochem Cell Biol. 2005 Oct;37(10):1985-96 PMID: 16125108
  44. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle.
    Mol Cell. 2001 May;7(5):1085-94 PMID: 11389854
  45. Regulation of muscle fiber type and running endurance by PPARdelta.
    PLoS Biol. 2004 Oct;2(10):e294 PMID: 15328533
  46. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway.
    EMBO J. 2001 Nov 15;20(22):6414-23 PMID: 11707412
  47. Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients.
    Clin Sci (Lond). 1993 Jun;84(6):651-4 PMID: 8334811
  48. Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice.
    Physiol Genomics. 2008 Feb 19;32(3):360-9 PMID: 18042831
  49. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity.
    J Clin Endocrinol Metab. 2007 Mar;92(3):1073-9 PMID: 17164301
  50. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes.
    Diabetes Care. 2006 Apr;29(4):895-900 PMID: 16567834
  51. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats.
    Diabetes. 1999 Feb;48(2):287-91 PMID: 10334303
  52. Alternative Gnas gene products have opposite effects on glucose and lipid metabolism.
    Proc Natl Acad Sci U S A. 2005 May 17;102(20):7386-91 PMID: 15883378
  53. Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.
    J Physiol. 2001 Sep 1;535(Pt 2):591-600 PMID: 11533147
Article Info
Journal
American journal of physiology. Cell physiology
Abbr.
Am J Physiol Cell Physiol
ISSN
0363-6143
Published
2009-04-00
Epub
2009-00-21
Pages
C930-40
Language
English
Region
United States
NLM ID
100901225
PMCID
PMC2670650
Subset
IM
Grants
NIAMS NIH HHS · AR-048816 · United States
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]